CAPRICOR THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-14.5M | $-14.6M | $192.0K | $2.0M |
| FY2017 | $-14.2M | $-14.3M | $32.2K | $1.7M |
| FY2018 | $-13.9M | $-14.2M | $316.5K | $1.7M |
| FY2019 | $-6.8M | $-6.8M | $0 | $701.0K |
| FY2020 | $-10.1M | $-10.6M | $547.6K | $2.0M |
| FY2021 | $-16.8M | $-18.0M | $1.2M | $3.0M |
| FY2022 | $4.9M | $2.9M | $2.0M | $4.5M |
| FY2023 | $-25.6M | $-26.9M | $1.3M | $7.4M |
| FY2024 | $-40.0M | $-41.2M | $1.2M | $9.8M |
| FY2025 | $-69.8M | $-72.7M | $2.9M | — |